ReShape Lifesciences, Inc.
Historical 13F Holders
Symbol
RSLS
CUSIP
76090R200
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q1
1
3.00
$1.00
$0
2024 Q4
1
3.00
$13.00
$0
2024 Q3
2
4.00
$24.00
$0
2024 Q2
19
388 k
$73.3 k
$0
2024 Q1
21
266 k
$49.1 k
$0
2023 Q4
16
435 k
$108 k
$0
2023 Q3
18
404 k
$135 k
$0
2023 Q2
12
104 k
$153 k
$0
2023 Q1
14
144 k
$371 k
$0
2022 Q4
11
1.69 k
$12.2 k
$0